SecBot SecBot
6-K ·Filed Mar 26, 2026

NVO

NOVO NORDISK A S
NEUTRAL
Impact 4/10
Horizonweeks Processed7mo ago SEC0001171843-26-001932
Notable filing: 6-K
Actionable Insight • Neutral

The dividend and buyback authorization suggest confidence in financial stability, but no new growth initiatives were announced. Investors should monitor future financial reports for signs of growth or margin pressures.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
NVO ▲ +33.22% at T+60d
NEUTRAL call +33.22% · α vs SPY +19.27% · entry $35.11 → $46.78
Entry = T+0 close
Mar 26, 2026
via day close
T+1d
-0.99%
call -0.99% · α +0.69%
$34.77
settled 7mo ago
T+5d
+5.32%
call +5.32% · α +3.69%
$36.98
settled 7mo ago
T+20d
+17.25%
call +17.25% · α +6.59%
$41.17
settled 6mo ago
T+60d
+33.22%
call +33.22% · α +19.27%
$46.78
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Novo Nordisk held its 2026 Annual General Meeting, approving its 2025 annual report, declaring a final dividend of DKK 7.95 per share (total dividend of DKK 11.70), re-electing board members, and authorizing share buybacks of up to 10% of its share capital. The company also extended its board's authority to increase share capital.

Key Facts

  • Approved 2025 annual report and distribution of profits
  • Declared final dividend of DKK 7.95 per share, bringing total 2025 dividend to DKK 11.70
  • Re-elected Lars Rebien Sørensen as chair and other board members
  • Authorized board to repurchase up to 10% of its share capital
  • Extended board's authority to increase share capital up to DKK 44,650,000 until April 2028

Financial Impact

Total dividend of DKK 11.70 per share for 2025, share buyback authorization for up to 10% of share capital

dividendshare countcapital structure

Risk Factors

  • No new strategic initiatives announced
  • Board re-election without changes may indicate limited governance evolution

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-001932
Document: 0001171843-26-001932-index-headers.html0001171843-26-001932
Document: 0001171843-26-001932-index.html0001171843-26-001932
Document: 0001171843-26-001932.txt0001171843-26-001932
35 reports for NVO
Performance horizon
83% Hit rate @ T+20 5 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +23.56%Jul 28, 2026
Filters
Rows
Reports for NVO — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
6-K
NEUTRAL ★ 2/10
$39.13awaiting T+20—$38.67 (−1.18%)
Oct 26, 2026
2d ago
Court Ruling
NEUTRAL ★ 4/10
$38.59awaiting T+20—$38.67 (+0.21%)
Oct 19, 2026
8d ago
6-K
NEUTRAL ★ 2/10
$38.42awaiting T+20—$38.67 (+0.65%)
Oct 13, 2026
14d ago
6-K
NEUTRAL ★ 2/10
$38.06awaiting T+20—$38.67 (+1.60%)
Oct 6, 2026
21d ago
6-K
NEUTRAL ★ 2/10
$37.53awaiting T+20—$38.67 (+3.04%)
Sep 28, 2026
29d ago
6-K
NEUTRAL ★ 2/10
$38.71 $38.95▲ +0.61%▲ +0.64%$38.67 (−0.10%)
Sep 23, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$38.62 $39.43▲ +2.10%▲ +2.52%$38.67 (+0.13%)
Sep 21, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$39.80 $38.42▼ −3.47%▼ −2.56%$38.67 (−2.84%)
Sep 17, 2026
5w ago
6-K
BULLISH ★ 6/10
$43.19 $39.22▼ −9.19%▼ −10.40%$38.67 (−10.47%)
Sep 15, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$42.53 $38.06▼ −10.51%▼ −13.23%$38.67 (−9.08%)
Showing 10 of 35

US Market Status

Market Closed — Opens Thu (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 26, 2026